lifestyle.pluralist.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
globenewswire
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025 – NEWSnet – News… as it used to be
More Press Releases
May 8, 2026
Previewing the Product Logic Behind Waton’s Next AI Trading Platform
May 8, 2026
Gruv Unveils AI-First Infrastructure for Global Money Movement
May 8, 2026
Hisense Unveils XR10: The Apex of Projector, Bringing Cinema Into Every Home
May 8, 2026
Transaction in Own Shares
